Madison-based Cellular Logistics has been awarded a $321,000 SBIR grant from the National Institutes of Health to facilitate the assembly of Tandem HF biomaterial to assist in heart failure treatment, according to a release from the company.
The grant aims to develop a second manufacturing pipeline of iPSC-CF cardiac fibroblasts to manufacture Cellular Logistics’ novel regenerative biomaterial designed to revitalize damaged heart tissue and create unique opportunities for cell/gene/protein–based combination therapies for patients.
